Pharmaceutical supply agreements
Original notice title
Germany – Pharmaceutical products – Arnzeimittelverträge mit Beitrittsoption
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
40 / 100
Risk factors
The notice states it is not subject to EU procurement directives or German competition law. Bidders may have limited le...
Critical information missing: estimated value, award criteria, eligibility criteria, required documents. Making informe...
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 3 lots
- Duration until Jun 2027
- Supply of pharmaceutical products: Denosumab (60 mg), Denosumab (120 mg), and Teriflunomid (N3) under framework agreements with accession option.
- Performance location: Wuppertal, Germany (DEA1A).
Show full summary
This notice is for framework agreements with accession option (Rahmenvertrag mit Beitrittsoption) for pharmaceutical products, specifically three lots: Denosumab 60 mg, Denosumab 120 mg, and Teriflunomid (N3). The buyer is BARMER Beschaffung und Vergabe, a German health insurance body. The notice explicitly states it is not a public procurement subject to EU directives (2014/24/EU) or German competition law; the 'open procedure' label is for form purposes only. No estimated value, award criteria, or eligibility criteria are provided. Submission is electronic via https://beschaffungen.barmer.de/ by 2027-05-01 10:00. The document language is German. There is an inconsistency in EU funding flag: structured data says true, XML says no EU funds.
Risks
The notice states it is not subject to EU procurement directives or German competition law. Bidders may have limited le...
Critical information missing: estimated value, award criteria, eligibility criteria, required documents. Making informe...
No procurement documents available
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Administrative
- Tenders must be submitted electronically via Open portal
- Submissions allowed in German language only.
- Bidders may submit tenders for up to 3 lots (maximum 3 lots).
Requirements may be incomplete.
Buyer
Location
Wuppertal, DEU
Website
Identifier
992-80322-57
Activity
Health
Lots (3)
LOT-0001
Denosumab (60 mg)
Framework agreement for medicinal products containing the active substance Denosumab (60 mg). Performance in Wuppertal, Germany. Duration: 2025-08-01 to 2027-06-30.
Location
Duration
Category
Deadline
Award details
Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoff/Wirkstoffkombination enthalten.
Value note
Show original TED data
Original TED description
Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoff/Wirkstoffkombination enthalten.
LOT-0002
Denosumab (120 mg)
Framework agreement for medicinal products containing the active substance Denosumab (120 mg). Performance in Wuppertal, Germany. Duration: 2025-08-01 to 2027-06-30.
Location
Duration
Category
Deadline
Award details
Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoff/Wirkstoffkombination enthalten.
Value note
Show original TED data
Original TED description
Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoff/Wirkstoffkombination enthalten.
LOT-0003
Teriflunomid (N3)
Framework agreement for medicinal products containing the active substance Teriflunomid (N3). Performance in Wuppertal, Germany. Duration: 2025-08-01 to 2027-06-30.
Location
Duration
Category
Deadline
Award details
Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoff/Wirkstoffkombination enthalten.
Value note
Show original TED data
Original TED description
Vertragsgegenständlich sind Arzneimittel, die den/die im Titel genannte(n) Wirkstoff/Wirkstoffkombination enthalten.
Procurement Details
- Publication date
- 18 Jun 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 398866-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
30 / 100
Complexity
40 / 100
Risk factors
The notice states it is not subject to EU procurement directives or German competition law. Bidders may have limited le...
Critical information missing: estimated value, award criteria, eligibility criteria, required documents. Making informe...
No procurement documents available
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications